Appropriate Use Criteria For Amyloid PET

Publication Date: January 1, 2013
Last Updated: March 14, 2022

Appropriate Indications

Patients with persistent or progressive unexplained mild cognitive impairment (MCI)
6731

Not Appropriate Indications

Patients with core clinical criteria for probable AD with typical age of onset
6731

Overview

Title

Appropriate Use Criteria For Amyloid PET

Authoring Organizations